Literature DB >> 9692848

A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity.

M M Nociari1, A Shalev, P Benias, C Russo.   

Abstract

In this study, a fluorometric method using alamarBlue has been developed for detecting cell-mediated cytotoxicity in vitro. AlamarBlue is a non-toxic metabolic indicator of viable cells that becomes fluorescent upon mitochondrial reduction. Specific lysis of targets by effector cells is quantified by comparing the total number of viable cells in wells containing effector and targets together, with wells where target and effector cells were separately seeded. Cell-mediated cytotoxic activity by alloreactive T cells and natural killer cells has been detected using a novel application of the alamarBlue technique. The assay that we have developed to detect cell-mediated cytotoxicity is extremely sensitive and specific and requires a significant lower number of effector cells than the standard 51Cr assay. Since alamarBlue reagent is non-toxic to cells and the assay can be performed under sterile conditions, effector cells may be recovered at the end for further analysis or cell expansion, if desired. Direct comparison of cell-mediated cytotoxicity measured by the alamarBlue method with the standard 51Cr release assay revealed that the former method is as specific and more sensitive than the conventional assay. Moreover, very small inter and intra-assay variations have been observed for alamarBlue cytotoxicity assays. In conclusion, this study shows that the alamarBlue assay is an extremely sensitive, economical, simple and non-toxic procedure to evaluate cell-mediated cytotoxicity that yields accurate results using a limited number of effector cells. Furthermore, since this assay is a one-step procedure, and does not involve any risk for the personnel, it may be useful to analyze automatically cell-mediated cytotoxicity in a large number of samples.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9692848     DOI: 10.1016/s0022-1759(98)00028-3

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  88 in total

1.  Inhibition of Fas-mediated apoptosis by antigen: implications for lymphomagenesis.

Authors:  Elaine J Schattner; Steven M Friedman; Paolo Casali
Journal:  Autoimmunity       Date:  2002-07       Impact factor: 2.815

2.  Selective induction of host genes by MVA-B, a candidate vaccine against HIV/AIDS.

Authors:  Susana Guerra; José Manuel González; Núria Climent; Hugh Reyburn; Luis A López-Fernández; José L Nájera; Carmen E Gómez; Felipe García; José M Gatell; Teresa Gallart; Mariano Esteban
Journal:  J Virol       Date:  2010-06-09       Impact factor: 5.103

3.  In vitro comparative assessment of different viability assays in Acanthamoeba castellanii and Acanthamoeba polyphaga trophozoites.

Authors:  I Heredero-Bermejo; J L Copa-Patiño; J Soliveri; R Gómez; F J de la Mata; J Pérez-Serrano
Journal:  Parasitol Res       Date:  2013-09-12       Impact factor: 2.289

4.  Three-dimensional laser micro- and nano-structuring of acrylated poly(ethylene glycol) materials and evaluation of their cytoxicity for tissue engineering applications.

Authors:  A Ovsianikov; M Malinauskas; S Schlie; B Chichkov; S Gittard; R Narayan; M Löbler; K Sternberg; K-P Schmitz; A Haverich
Journal:  Acta Biomater       Date:  2010-10-25       Impact factor: 8.947

5.  Assessment of cell viability in a three-dimensional enzymatically cross-linked collagen scaffold.

Authors:  Y Garcia; R Collighan; M Griffin; A Pandit
Journal:  J Mater Sci Mater Med       Date:  2007-06-07       Impact factor: 3.896

6.  Cell type-specific aspects in biocompatibility testing: the intercellular contact in vitro as an indicator for endothelial cell compatibility.

Authors:  Kirsten Peters; Ronald E Unger; Susanne Stumpf; Julia Schäfer; Roman Tsaryk; Bettina Hoffmann; Eva Eisenbarth; Jürgen Breme; Günter Ziegler; C James Kirkpatrick
Journal:  J Mater Sci Mater Med       Date:  2007-10-04       Impact factor: 3.896

7.  Bioactivation of calcium deficient hydroxyapatite with foamed gelatin gel. A new injectable self-setting bone analogue.

Authors:  M Dessì; M A Alvarez-Perez; R De Santis; M P Ginebra; J A Planell; L Ambrosio
Journal:  J Mater Sci Mater Med       Date:  2013-10-18       Impact factor: 3.896

8.  Combined arene ruthenium porphyrins as chemotherapeutics and photosensitizers for cancer therapy.

Authors:  Frédéric Schmitt; Padavattan Govindaswamy; Olivier Zava; Georg Süss-Fink; Lucienne Juillerat-Jeanneret; Bruno Therrien
Journal:  J Biol Inorg Chem       Date:  2008-09-23       Impact factor: 3.358

9.  Differential mechanisms of shedding of the glycosylphosphatidylinositol (GPI)-anchored NKG2D ligands.

Authors:  Lola Fernández-Messina; Omodele Ashiru; Philippe Boutet; Sonia Agüera-González; Jeremy N Skepper; Hugh T Reyburn; Mar Valés-Gómez
Journal:  J Biol Chem       Date:  2010-01-14       Impact factor: 5.157

10.  Membrane disruption by antimicrobial fatty acids releases low-molecular-weight proteins from Staphylococcus aureus.

Authors:  Joshua B Parsons; Jiangwei Yao; Matthew W Frank; Pamela Jackson; Charles O Rock
Journal:  J Bacteriol       Date:  2012-07-27       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.